Form 8-K - Current report:
SEC Accession No. 0001213900-20-037753
Filing Date
2020-11-17
Accepted
2020-11-17 17:00:15
Documents
5
Period of Report
2020-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea129705-8k_americanbri.htm 8-K 34725
2 FORM OF WARRANT ISSUED TO THE INVESTORS PURSUANT TO THE SPA ea129705ex4-1_americanbri.htm EX-4.1 61223
3 FORM OF SPA ENTERED INTO BY AND BETWEEN THE COMPANY AND THE INVESTOR ea129705ex10-1_americanbri.htm EX-10.1 89834
4 FORM OF AMENDMENT TO SPA ENTERED INTO BY AND BETWEEN THE COMPANY AND THE INVESTO ea129705ex10-2_americanbri.htm EX-10.2 17682
5 FORM OF REGISTRATION RIGHTS AGREEMENT ENTERED INTO BY AND BETWEEN THE COMPANY AN ea129705ex10-3_americanbri.htm EX-10.3 47619
  Complete submission text file 0001213900-20-037753.txt   252546
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-91436 | Film No.: 201321856
SIC: 2834 Pharmaceutical Preparations